when did glp-1 drugs become popular History of Medications Only one in 12 remain

Tirzepatide was approved in 2022 as Mounjaro for diabetes, and in 2024 as Zepbound for obesity, with exclusivity running until May 2027

Same-day prescriptions and immediate shipping

So, it's no surprise that several wellness- and supplement-focused brands have launched products intended to meet the moment, though each of the products discussed in this piece positions itself slightly differently and uses different ingredients

Start your weight loss today with coaching, a metabolic test and medication at an affordable price.

These drugs have recently become more comm

The global GLP-1 agonists market is expected to reach USD 170.75 billion in 2033 from USD 64.42 billion in 2025 at a CAGR of 13.0% during the forecast period